Related by context. All words. (Click for frequent words.) 75 kidney urologic 73 TRACON Pharmaceuticals 73 Crofelemer budesonide foam 73 XL# anticancer compounds 73 subsidiaries visit http:/www.apricusbio.com 73 Archexin 73 candidates Azedra TM 73 purinergic receptors P#X# 73 induced macular edema 72 LymphoStat B belimumab 72 IMiDs ® 72 novel VDA molecule 72 Achieves Primary Endpoint 72 oncolytic virus therapies 72 LymphoStat B TM 72 Initiates Phase II 72 mertansine 72 ALN PCS 71 acetonide FA 71 developing Bicifadine serotonin 71 AAG geldanamycin analog 71 targeted radiotherapeutic 71 CYT# potent vascular disrupting 71 signal averaging electrocardiography 71 rxRNA 71 MKC# MT 71 Completes Patient Enrollment 71 Selective Electrochemical Tumor Ablation 71 anticancer therapeutics 71 Initiates Clinical Trial 71 IMiDs ® compound 71 Begins Dosing 70 acyclovir Lauriad R 70 SinuNase ™ 70 SinuNase TM 70 SPRYCEL ® 70 Personalized Immunotherapy 70 Provectus Pharmaceuticals specializes 70 CD# CEA 70 candidate CRLX# 70 liposomal formulation 70 GVAX ® 70 targeted anticancer biopharmaceuticals 70 oral ghrelin agonist 70 vapreotide acetate 70 tiapamil 70 CTAP# Capsules 70 MAGE A3 ASCI 70 IMiDs R 70 non nucleoside inhibitor 70 Initiates Enrollment 70 Solazed TM 70 oral prodrug 70 DP VPA 70 highly selective inhibitor 70 MCSP respectively 70 HuMax TAC 70 Initiates Clinical Trials 70 oral nucleoside analogue 70 sapacitabine CYC# 70 candidate XP# 70 R sorafenib tablets 70 Panzem R 70 Evoltra ® 70 agonistic human 69 MTP inhibitor 69 AKT inhibitor 69 prokinetic agent 69 personalized cellular immunotherapy 69 Combivir Kivexa 69 Exherin 69 rusalatide acetate 69 please visit www.advaxis.com 69 CCR9 antagonist 69 ALN HPN 69 Behcet uveitis 69 volociximab 69 Aganocide ® 69 ChromoCure develops 69 Optiquel ™ 69 Ceflatonin R 69 FOLOTYN ® 69 SPL# Gel vaginal microbicide 69 Silodosin 69 orally administered inhibitor 69 MOVIPREP R 69 Budesonide foam crofelemer 69 ® bortezomib 69 apricitabine ATC 69 Submits Response 69 Receives Orphan Drug Designation 69 Immunotherapeutic 69 PI3K/Akt pathway inhibitor 69 molecular chaperone regulation 69 HCV RNA polymerase 69 adenosine A2A 69 Zalypsis 69 Ostabolin C TM 69 cosmetic cosmeceutical products 69 novel immunotherapies 69 PEGylated interferon 69 PORxin TM platforms 69 Pruvel ™ 69 gastrointestinal disorders ATI 69 Therapeutic Competitors companiesandmarkets.com adEgemonye 69 delivery polymer matrix 69 Initiates Clinical 69 PDE4 inhibitor 69 romazarit 68 Nanobody R 68 humanized therapeutic 68 ulimorelin 68 Therapeutic Competitors Companies 68 vaccines oncolytic virus 68 Marqibo TM 68 Potelligent Technology 68 aldehyde dehydrogenase ALDH2 deficiency 68 visit http:/www.mannkindcorp.com 68 please visit www.medicinova.com 68 Fc fusion protein 68 Tesmilifene 68 proprietary capillary aerosolization 68 delta opioid receptor 68 pipeline ImmunoGen collaborators 68 HCV protease inhibitors 68 novel emulsion formulation 68 small molecule glucokinase 68 targeted immunotherapies 68 Initiates Dosing 68 Genentech sanofi aventis 68 TRANSDUR ™ 68 therapeutic monoclonal antibodies 68 Aeolus Pharmaceuticals Announces 68 NS5b 68 product platforms AZX# 68 EHT AGN 68 antibacterial therapeutics 68 gastro intestinal inflammation 68 recombinant biopharmaceutical 68 essential thrombocythemia ET 68 visit www.genenews.com 68 R MSCRAMM 68 introduced NEUGENE 68 MKC# MKC# PP 68 novel antibody therapeutics 68 RECOTHROM R 68 refractory chronic lymphocytic 68 successfully commercialize Iluvien 68 proprietary BiTE ® 68 MKC# 68 HGS ETR1 mapatumumab 68 Ecallantide 68 oral picoplatin 68 telomerase inhibitor drug 68 TRIOLEX HE# APOPTONE HE# 68 proprietary polysaccharide 68 peptibody 68 Kosan dependence 68 Inc. www.micromet inc.com 68 psoriasis rheumatoid arthritis 68 inflammatory autoimmune diseases 68 treat chronic sinusitis 68 IAP inhibitor 68 Virulizin ® 68 Namenda Memantine HCl 68 NovaBay Aganocide compounds 68 pharmacogenomic translational research 68 anti infective treatments 68 platform HDL Mimetic 68 IMiDs 68 HCD# [002] 68 beta 1a 68 2A receptor agonist 67 ATL# [002] 67 novel therapeutic antibodies 67 Cimzia TM 67 oral proteasome inhibitor 67 either acutely decompensated 67 mGluR2 positive 67 nucleotide analog 67 investigational monoclonal antibody 67 RANK Ligand inhibitor 67 Pruvel TM 67 Meets Primary Endpoint 67 TNF Tumor Necrosis Factor 67 proteasome inhibitor 67 Friedreich Ataxia FRDA 67 HCV polymerase inhibitors 67 XL# XL# XL# XL# 67 cathepsin K inhibitor 67 Omacetaxine 67 manufactures minimally invasive 67 AMPK activators 67 pralatrexate injection folate analogue 67 Empatic ™ 67 neuro inflammatory disorders 67 Presents Preclinical 67 candidate deforolimus 67 Maxy G# 67 LEVADEX TM 67 TRIOLEX ™ 67 Telik logo TELINTRA 67 VitiGam 67 Survivin antagonist 67 2 inhibitor CYT# 67 antibody MAb 67 trastuzumab DM1 T DM1 67 peptidic compound 67 YONDELIS 67 RNAi therapeutic targeting 67 TM Aganocide 67 telomerase therapeutic 67 Peginterferon alfa 2b 67 developing ACAPODENE 67 PRT# 67 include Altastaph TM 67 OMNARIS Nasal Spray 67 Zorbtive TM 67 PF # [002] 67 StromaCel Inc. 67 PHX# 67 HCV polymerase 67 OTCBB PYTO 67 Surfactant Replacement Therapies SRT 67 Insegia 67 antiangiogenesis therapies 67 Panzem R NCD 67 Quinamed 67 CORT # 67 interferon gamma 1b 67 GW# [003] 67 Initiate Clinical Trial 67 Fludara ® 67 Genasense ® oblimersen 67 ZADAXIN ® 67 TELINTRA R 67 Valortim TM 67 Pemphigus Vulgaris 67 COLAZAL R 67 investigational humanized monoclonal antibody 67 Liprotamase 67 product candidate Lpathomab 67 commercializing oxidized glutathione 67 Selzentry Celsentri 67 Alfacell proprietary ribonuclease 67 Albuferon albinterferon alfa 2b 67 JAK2 inhibitor 67 reslizumab 67 non nucleoside HCV 67 TRANSDUR ® 67 candidate TNFerade biologic 67 Oracea TM 67 anticancer compound 67 diabetes irritable bowel 67 Successfully Completes Phase 67 PAION AG ISIN 67 Shigamabs ® 67 recurrent metastatic ovarian cancer 67 PSN# [001] 67 Predictive medicine 67 Phase Ib IIa 67 Presents Positive Preclinical 67 Regeneron Pharma 67 Ceragenin ™ 67 PDE# inhibitors 67 RECOTHROM ® 67 Vitrasert R 67 Taiho Pharmaceutical 67 symbol AVXL 67 Locked Nucleic Acid 67 lead molecular radiotherapeutic 67 DPX Survivac 67 SPRIX ® 67 THR beta agonist 67 Hepatitis C HCV 67 small molecule thrombopoietin 67 2 methoxyestradiol 67 oral Hsp# inhibitor 67 NuMimetic TM 67 prostone 67 BCR ABL inhibitors 67 MSCRAMM R 67 FDA APPROVES 67 Phase #b/#a clinical 67 generation purine nucleoside 67 thetreatment 67 International LAB Pharma 67 Initiates Phase III 67 MEK Inhibitor 67 MEDA AB publ 67 Reports Preclinical Data 67 Hsp# Inhibitor 67 PDX pralatrexate 66 orally bioavailable mimics 66 ARIKACE ™ 66 5 lipoxygenase inhibitor 66 RNAi therapeutic platform 66 Exelixis compounds 66 lomitapide 66 aerosolized AAT 66 Albugon 66 Revimmune TM 66 SCIB1 66 ALN HTT 66 Gentamicin Surgical Implant 66 Prodarsan R 66 accumulate preferentially 66 candidates Azedra 66 TransVax ™ 66 Pegloticase 66 Cypress Bioscience Inc 66 please visit http:/www.vandapharma.com 66 AFREZZA TM 66 BiTE R 66 VentiRx Pharmaceuticals 66 neuronal nicotinic receptor NNR 66 post herpetic neuralgia PHN 66 Zenvia ™ 66 ALN TTR 66 Mg Usa 66 virus HCV protease inhibitor 66 Spiegelmer ® 66 OMNARIS HFA 66 INTEGRILIN R eptifibatide Injection 66 novel immunomodulatory 66 RELOVAIR ™ 66 Files IND 66 ZaBeCor 66 formerly LymphoStat B 66 TKB# 66 Inc Therapeutic Competitors 66 investigational immunotherapy 66 compound PMX # 66 dimebon latrepirdine 66 please visit www.lexpharma.com 66 sorafenib tablets 66 delivers fluocinolone acetonide FA 66 Squalamine 66 SAR# [002] 66 Veronate R 66 topically applied SEPA 66 CRMD# 66 Nasdaq MITI biopharmaceutical 66 mGluR2 NAM 66 NASH Huntington 66 AzaSite TM 66 GED aPC 66 Receives Milestone Payment 66 monoclonal antibody MAb 66 Genentech Rituxan 66 idiopathic thrombocytopenic purpura ITP 66 intranasal formulation 66 brand ciclesonide HFA 66 Nasdaq HALO biopharmaceutical 66 sulfonylhydrazine class 66 Nasdaq LXRX biopharmaceutical 66 immunotherapeutic approaches 66 programs visit http:/www.bionovo.com 66 Asthma COPD 66 Xanafide 66 products MKC# PP 66 lintuzumab SGN 66 proprietary radiolabeled monoclonal 66 Serostim ® 66 including eniluracil ADH 66 CD4 monoclonal antibody 66 inhibit oxidative stress 66 hypoxia activated prodrug 66 lucinactant 66 Amigal TM 66 OTCBB IMNR 66 Daclizumab 66 evaluating picoplatin 66 please visit http:/www.sunesis.com 66 TPI ASM8 66 deCODE AF TM 66 treat male hypogonadism 66 XL# XL# 66 IG HCR ;) CO 66 infectious diseases autoimmune diseases 66 Announces Poster Presentations 66 Novel Oral 66 AcryMed Incorporated 66 Zemiva TM 66 Solzira ™ 66 commercialize Aganocides 66 transthyretin mediated amyloidosis ATTR 66 JAK inhibitors 66 BiovaxID TM 66 albiglutide 66 HCV protease inhibitor 66 MSCRAMM ® 66 generation radiolabeled antibody 66 Ribavirin causes 66 Curaxin CBLC# 66 dextromethorphan quinidine 66 based pretargeting methods 66 Vitamin D analogue 66 metaglidasen 66 nitric oxide donating prostaglandin 66 Combination REOLYSIN R 66 NB S# strontium malonate 66 Adnectin 66 synthetic retinoid 66 Surfaxin LS 66 ospemifene 66 Bosutinib 66 MEDAREX 66 JAK1 66 drug pipeline TAFA# 66 Atripla combines 66 Resurgex Plus R 66 LEVADEX ™ 66 visit www.genmab.com 66 Submits Biologics License Application 66 RNA antagonists 66 hypertension osteoarthritis 66 memantine HCl 66 AzaSite Xtra 66 JAK inhibitor 66 OvaRex R 66 oral taxane 66 biotherapeutic drugs 66 R Saizen R 66 NTDDS 66 PEGylated anti 66 bardoxolone 66 developing ostarine selective 66 drug ISA# 66 RhuDex R 66 ELND-#/AZD-# 66 humanized monoclonal 66 Receives Orphan Drug 66 Fortical R 66 Protexia ® 66 fusion enhancers 66 Captisol ® 66 developing TB4 66 pharmacological chaperone 66 nasal calcitonin product 66 Safinamide 66 small molecule tyrosine 66 platinum chemotherapeutic 66 NUEDEXTA ™ 66 dutogliptin 66 RhuDex ® 66 ArQule Kinase Inhibitor Platform 66 Xcytrin R 66 Trastuzumab DM1 66 nucleoside tide 66 CINQUIL 66 ocular formulation 66 Ridaforolimus 66 anti CD3 monoclonal 66 SAR# [004] 66 Delta opioid receptor 66 Aganocide TM 66 molecular imaging radiopharmaceutical 66 investigational oral inhibitor 66 Ception Therapeutics 66 RNA antagonist 66 Nasdaq IDIX 66 Presents Preclinical Data 66 dasatinib Sprycel 66 interferon alpha IFN 66 Cx# [002] 66 Kuvan R 66 rheumatoid arthritis thrombocytopenia 66 multi kinase inhibitor 66 G#DT 66 BXT # 66 POTELLIGENT ® 66 methylnaltrexone bromide 66 LHRH antagonists 66 ImmunoGen TAP technology 66 Septin9 biomarker 66 inhaled AAT 66 novel DACH platinum 66 Onalta TM 66 ATIR ™ 66 Factor VIIa 66 QUADRAMET R 66 Aganocide 66 phase IIb trial 65 Systemic Delivery 65 catheter occlusion 65 VYVANSE TM lisdexamfetamine 65 next generation URAT1 65 tubulin inhibitor 65 vinorelbine tartrate 65 evaluating tivozanib 65 Phase IIb Trial 65 Drug Candidate 65 Simulect 65 adrenergic regulation 65 t2cure GmbH 65 Bezielle 65 MorphoSys proprietary 65 ATRA IV 65 Allovectin 7 65 PEG SN# 65 investigational pharmacologically unique 65 cMET inhibitor 65 ALN RSV program 65 Homspera ® 65 Panzem ® 65 mitogen activated ERK kinase 65 Elagolix 65 proprietary intravenous formulation 65 TRAIL receptor antibodies 65 Romiplostim 65 novel histone deacetylase 65 STRIANT ® testosterone buccal 65 Initiates Phase 2b 65 Cetrorelix 65 Announce License Agreement 65 Iluvien ® 65 diarrhea predominant irritable 65 PORxin TM 65 ADCC enhanced 65 OncoVex 65 Hedgehog Pathway Inhibitor 65 external counterpulsation systems 65 overactive bladder VANTAS R 65 Tramiprosate ALZHEMED TM 65 technology visit http:/www.genmab.com 65 Pharma Merck Serono 65 Licenses Novel 65 GlycoPEGylated hemostasis compounds 65 ionotropic glutamate receptor antagonists 65 vidofludimus 65 Tezampanel 65 ARRY # 65 TOCOSOL Camptothecin 65 novel synthetic PEGylated 65 myocardial infarction ventricular fibrillation 65 Sanvar R 65 psoriasis Crohn disease 65 MediGene focuses 65 Thiovir 65 Proquin XR 65 PGL# 65 endothelin antagonist 65 Glufosfamide 65 PrevOnco ™ 65 NUVIGIL ® 65 targeting miR 65 PREOS R 65 vaginal candidiasis 65 toenail onychomycosis 65 BUPHENYL R 65 Phusion Laboratories 65 DermTech International 65 HuMax 65 refractory gout 65 Nanobody 65 KAI Pharmaceuticals Inc. 65 Inc. AMEX YMI 65 PNP inhibitor 65 markets HP Acthar 65 OTC BB PVCT 65 Alzheimer disease cognitive impairment 65 PEGylated Fab fragment 65 RTP #i 65 MUSE ® 65 glucokinase activator 65 lexidronam injection 65 ViroChem 65 GTC recombinant human 65 INxin TM 65 Campath ® 65 Presents Positive 65 UPLYSO 65 Zolpimist ™ 65 Phase 2b Clinical Trial 65 histamine dihydrochloride 65 diagnostic molecular imaging 65 GERD migraine headaches 65 Enzyme Replacement Therapy 65 ALTROPANE R 65 www.pranabio.com 65 oral Janus kinase 65 INSPIRE Trial Phase III 65 Adenosine Therapeutics 65 BCG refractory carcinoma 65 cardio renal 65 topical anti infective 65 serine protease inhibitor CU# 65 oral dihydropyrimidine dehydrogenase DPD 65 R#/MEM 65 Thiarabine 65 GI motility disorders 65 ZFP Therapeutics 65 faropenem medoxomil 65 OTCBB HNAB 65 DIFICID ™ 65 VISICOL R 65 DNA RNA Medicines 65 Locked Nucleic Acid LNA 65 please visit www.tranzyme.com 65 hypoxia selective 65 Peyronie disease Frozen Shoulder 65 initiated Phase 1b 65 CIMZIA ™ 65 developing Zerenex ferric 65 label Lipofen R 65 BENLYSTA TM 65 CombinatoRx Incorporated 65 progressive metastatic prostate 65 REGN# 65 CYP#A# CYP#D# 65 Interferon beta 65 please visit www.dyax.com 65 Intravenous Human 65 nilotinib Tasigna 65 forodesine 65 By JAMAAL ABDUL 65 www.vivus.com 65 BHT DNA 65 acne impetigo 65 Amgen Neulasta R 65 visit www.sciclone.com 65 5 HT3 antagonist 65 TLR antagonists 65 attach auristatin 65 selective adenosine 65 Oxis International 65 dihydrochloride Tablets 65 class mGluR5 inhibitor 65 Cerashield 65 Phase IIb clinical trials 65 telaprevir VX 65 Targeted Chemotherapy 65 selective estrogen receptor modulator 65 PrevOnco 65 LungAlert TM 65 hereditary emphysema 65 Aflibercept 65 INDICATED LOWER 65 Mg Uk 65 InterfeRx 65 please visit http:/www.atherogenics.com 65 REMINYL ® 65 tests miRview TM 65 Janus kinase 65 Aurora Kinase 65 autoimmune uveitis 65 Gleevec imatinib mesylate 65 AKIP ™ 65 CysDisplay R 65 intranasal delivery 65 novel orally inhaled 65 cognitive impairment associated 65 Luveris R Ovidrel R 65 pan histone deacetylase 65 ZEVALIN ® 65 NADiA R 65 Modrenal R 65 lumiliximab 65 Femring ® 65 secretory phospholipase A2 65 Enzon Pharmaceuticals Inc 65 topical gel formulation 65 small molecule Hedgehog 65 R bendamustine hydrochloride 65 candidate epratuzumab 65 induced mucositis 65 Vaccine Adjuvant 65 treat opioid induced 65 Anavex #-# 65 HQK 65 histone deacetylase HDAC inhibitor 65 Tibotec BVBA 65 STEDESA 65 Dementia Related Psychosis 65 REMICADE infliximab 65 norepinephrine reuptake inhibitor 65 molecular imaging radiopharmaceuticals 65 ABLYNX 65 AeroLEF R 65 NYSE Amex PBTH 65 Commences Phase 65 isoform selective 65 SomatoKine 65 Eraxis 65 constipation OIC 65 taxane derivative 65 monoclonal antibody therapeutics 65 peptide peptide mimetic 65 rasagiline tablets 65 biased ligand 65 Vidaza R 65 Submits NDA 65 Therapeutic Modeling Protocols 65 Onconase 65 allosteric modulator PAM 65 highly purified pasteurized 65 Cleviprex TM clevidipine 65 Bayer HealthCare Onyx Pharmaceuticals 65 R rilonacept Injection 65 candidate NGX 65 combines bupropion 65 APC Targeting Technology 65 Epiphany Biosciences 65 JAK2 Inhibitor 65 Aganocide R 65 MT#/MEDI-# 65 treats acute lymphoblastic 65 GMX# 65 orally inhaled 65 alpha antagonist 65 Maribavir 65 Nicotine Conjugate Vaccine 65 Aloprim TM allopurinol sodium 65 FACTIVE R gemifloxacin 65 Inc. Nasdaq IMGN 65 include Healive TM 65 erlotinib Tarceva ® 65 Supernus Pharmaceuticals 65 Azmacort R 65 Ampakine compounds 65 Onalta 65 sodium Injection 65 sJIA 65 therapeutic peptide 65 investigational oral hepatitis C 65 retinal vein occlusion induced 65 Gamunex C 65 CIMZIA r 65 dermatology therapies 65 Albuferon TM 65 expanded autologous cellular 65 muscarinic receptor agonist 65 mild vasodilator 65 mesylate tablets approved 65 therapeutic monoclonal antibody 65 include ColorectAlert TM 65 neuro inflammatory 64 Annamycin 64 Genasense R oblimersen 64 vaginally administered lidocaine 64 SYCREST 64 optical biosensors 64 ENTOCORT EC 64 ® daptomycin 64 RAPTIVA 64 Epidermal Growth Factor Receptor 64 Nasdaq VRTX 64 immuno therapeutic 64 Nanobody ® 64 IMiD 64 HIV integrase inhibitors 64 Kuvan sapropterin dihydrochloride 64 reversible inhibitor 64 class anticancer quinolone 64 incyclinide 64 Droxidopa Chelsea 64 Nasdaq IDRA today 64 FOLFOX6 chemotherapy regimen 64 pradefovir 64 EnteroMedics proprietary neuroblocking technology 64 AMEX RGN 64 synthetic peptide containing 64 mGluR5 PAM 64 riboflavin vitamin B2 64 XP# XP# 64 Agonist MABA program 64 using ImmunoGen TAP 64 Neulasta R 64 Discovery Labs KL4 64 commercializing Loramyc ® 64 website www.celsion.com 64 selective modulator 64 Asentar TM 64 hyperimmune products 64 dermatological diseases 64 highly selective adenosine 64 include VALSTAR TM 64 transthyretin TTR 64 Cytogen marketed 64 commercialize XP# 64 Bucindolol 64 developing chemokine 64 Bioral Amphotericin B 64 PSMA ADC 64 valopicitabine NM# 64 HepaMate 64 oral anti arrhythmic 64 Captisol enabled 64 microsurgical disciplines 64 Orally administered 64 RAS MAPK pathway 64 UltiMAb 64 fatty acid amide hydrolase 64 Pyridorin 64 neovascular diseases 64 small molecule agonists 64 novel proprietary KL4 64 HIV integrase inhibitor 64 demonstrated antitumor activity 64 Fodosine 64 Crucell PER.C6 64 seliciclib CYC# 64 Gel repository corticotropin injection 64 novel peptide 64 Fortical ® 64 oropharyngeal candidiasis OPC 64 commercialize SGN 64 acadesine 64 ASE SVA 64 About Positron Positron 64 Phase IIa Clinical Trial 64 Azedra 64 London AiM GLPG 64 Demonstrates Significant 64 Hedgehog pathway inhibitor 64 antisense inhibitors 64 polyneuropathy HIV DSP 64 sodium glucose cotransporter 64 opioid induced bowel dysfunction 64 Xeloda ® 64 Soliris eculizumab 64 thalidomide Thalomid 64 GSK '# 64 granisetron formulated 64 Microplasmin 64 pan HDAC inhibitor 64 Lexiscan ® 64 Civacir 64 severe gastroparesis 64 Cancidas 64 oral immunomodulatory 64 IgG1 monoclonal antibody 64 regorafenib 64 biologic therapeutics 64 Oncosphere System 64 Fast Track Status 64 Gets FDA Clearance 64 drug GAP #B# 64 investigational therapies 64 Panzem 64 SIX RO ROG 64 sodium glucose transporter 64 YONDELIS R 64 Rilonacept 64 researches develops licenses 64 dirucotide MBP# 64 novel anti infective 64 proprietary intranasal insulin 64 humanized interleukin 6 64 mTOR kinase 64 Pimavanserin 64 modified glutathione analog 64 Epratuzumab 64 Creabilis Therapeutics 64 skeletal sarcomere activators 64 IMMU 64 Piperacillin 64 DURECT proprietary 64 catalytic antioxidant compounds 64 visit www.targanta.com 64 Troxatyl 64 BARACLUDE R 64 Inotek Pharmaceuticals Corporation 64 Nasdaq ONXX 64 DEB# 64 TKPHF 64 Nasdaq CLDX 64 selective immunoproteasome inhibitor 64 faropenem 64 intravesical infusion therapy 64 docetaxel Taxotere R 64 EGS# 64 Ciclesonide 64 palonosetron hydrochloride Injection Dacogen 64 Ophthotech 64 Sulonex TM 64 targeted antifolate 64 Prednisporin 64 VEGFR2 inhibitor 64 nalbuphine ER 64 Alnylam Nasdaq ALNY 64 TÎ ² 4 64 JOULFERON 64 commercialize becocalcidiol patented 64 Tß4 64 hyperphenylalaninemia HPA due 64 provides RevColor RevDisplay 64 selective agonist 64 preclinical efficacy 64 paclitaxel Taxol ® 64 Schering Plough Remicade 64 adenosine injection 64 Oral NKTR 64 Tumour Vascular Disrupting Agent 64 BUPHENYL 64 PRTX 64 Sapacitabine 64 anti botulism antibody 64 compound INCB# 64 tramiprosate Alzhemed TM 64 tumor activated prodrug 64 potent antiproliferative 64 AEG# 64 sapropterin dihydrochloride 64 IPL# 64 Locteron exclusively 64 candidate Zenvia 64 CDP# 64 immunotherapeutic vaccine 64 ATL# [001] 64 patented Bioral 64 Receives Approvable Letter 64 Alvine Pharmaceuticals 64 Granted Orphan Drug 64 Temsirolimus 64 LibiGel ® 64 Arno Therapeutics 64 NeutroSpec TM 64 phase III isavuconazole 64 GLP1 INT TM 64 5 HT2A inverse 64 TELINTRA 64 Tyrosine Kinase Inhibitor 64 By JENNIFER LEARN 64 TBC# 64 Nexavar ® 64 Receives Fast Track 64 NanoTab 64 BioSante Pharmaceuticals Announces 64 Thrombin topical Recombinant 64 PMX # heptagonist 64 IV Busulfex 64 proprietary PEGylation 64 Epothilones 64 using VIAdel TM 64 commercialize Dimebon 64 POTELLIGENT ® Technology 64 ALN TTR# 64 Pafuramidine 64 Rigel R# 64 Merck OSI Pharmaceuticals 64 markets Testim ® 64 ThermoDox R 64 Phase Ib II 64 Nasdaq IMGN 64 commercializing therapeutic 64 novel oral anticoagulant 64 Retisert ® 64 Taglich Brothers Initiates Coverage 64 Vicriviroc 64 Trofex TM 64 Aradigm Logo 64 Genaera Corporation 64 GRNOPC1 contains 64 r hGH 64 Acetavance TM intravenous acetaminophen 64 ularitide 64 oral salmon calcitonin 64 Nasdaq AEGR 64 Angiocept 64 Nasdaq RDEA 64 Nasdaq AVNR 64 Epigenomics proprietary 64 ThermoDox ® clinical 64 Akesis Pharmaceuticals 64 4SC AG ISIN DE# 64 pathophysiological effects 64 doxepin HCl 64 vitreoretinal disorders 64 GVAX cancer 64 calcium phosphate nanotechnology CaP 64 secondary hyperparathyroidism 64 motexafin gadolinium Injection 64 Tarceva TM 64 var arrContent = 64 Lixivaptan 64 Talabostat 64 intravenous acetaminophen 64 delay bone metastases 64 Vascular Wrap TM 64 anaphylactic reactions bronchospasm 64 ® lenalidomide 64 novel RNAi therapeutics 64 KRYSTEXXA TM pegloticase 64 AERx iDMS 64 Aviptadil 64 adecatumumab MT# 64 benign prostatic hypertrophy BPH 64 basal cell carcinoma squamous 64 Vitrasert ® 64 treat hyperproliferative disorders 64 BrachySil TM 64 rhIGF-I/rhIGFBP-3 64 Alexza Pharmaceuticals Inc 64 XL# XL# XL# 64 candidates bavituximab 64 Actemra tocilizumab 64 gefitinib Iressa